IBDEI2L2 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,41226,2)
;;=^5002659
;;^UTILITY(U,$J,358.3,41227,0)
;;=E11.638^^152^2030^29
;;^UTILITY(U,$J,358.3,41227,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41227,1,3,0)
;;=3^DM Type 2 w/ Oth Oral Compl
;;^UTILITY(U,$J,358.3,41227,1,4,0)
;;=4^E11.638
;;^UTILITY(U,$J,358.3,41227,2)
;;=^5002660
;;^UTILITY(U,$J,358.3,41228,0)
;;=E11.641^^152^2030^20
;;^UTILITY(U,$J,358.3,41228,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41228,1,3,0)
;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
;;^UTILITY(U,$J,358.3,41228,1,4,0)
;;=4^E11.641
;;^UTILITY(U,$J,358.3,41228,2)
;;=^5002661
;;^UTILITY(U,$J,358.3,41229,0)
;;=E11.649^^152^2030^21
;;^UTILITY(U,$J,358.3,41229,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41229,1,3,0)
;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
;;^UTILITY(U,$J,358.3,41229,1,4,0)
;;=4^E11.649
;;^UTILITY(U,$J,358.3,41229,2)
;;=^5002662
;;^UTILITY(U,$J,358.3,41230,0)
;;=E11.65^^152^2030^17
;;^UTILITY(U,$J,358.3,41230,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41230,1,3,0)
;;=3^DM Type 2 w/ Hyperglycemia
;;^UTILITY(U,$J,358.3,41230,1,4,0)
;;=4^E11.65
;;^UTILITY(U,$J,358.3,41230,2)
;;=^5002663
;;^UTILITY(U,$J,358.3,41231,0)
;;=E11.69^^152^2030^32
;;^UTILITY(U,$J,358.3,41231,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41231,1,3,0)
;;=3^DM Type 2 w/ Oth Spec Compl
;;^UTILITY(U,$J,358.3,41231,1,4,0)
;;=4^E11.69
;;^UTILITY(U,$J,358.3,41231,2)
;;=^5002664
;;^UTILITY(U,$J,358.3,41232,0)
;;=E11.8^^152^2030^34
;;^UTILITY(U,$J,358.3,41232,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41232,1,3,0)
;;=3^DM Type 2 w/ Unspec Compl
;;^UTILITY(U,$J,358.3,41232,1,4,0)
;;=4^E11.8
;;^UTILITY(U,$J,358.3,41232,2)
;;=^5002665
;;^UTILITY(U,$J,358.3,41233,0)
;;=E11.9^^152^2030^35
;;^UTILITY(U,$J,358.3,41233,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41233,1,3,0)
;;=3^DM Type 2 w/o Complications
;;^UTILITY(U,$J,358.3,41233,1,4,0)
;;=4^E11.9
;;^UTILITY(U,$J,358.3,41233,2)
;;=^5002666
;;^UTILITY(U,$J,358.3,41234,0)
;;=E11.29^^152^2030^27
;;^UTILITY(U,$J,358.3,41234,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41234,1,3,0)
;;=3^DM Type 2 w/ Oth Diab Kidney Compl
;;^UTILITY(U,$J,358.3,41234,1,4,0)
;;=4^E11.29
;;^UTILITY(U,$J,358.3,41234,2)
;;=^5002631
;;^UTILITY(U,$J,358.3,41235,0)
;;=E11.311^^152^2030^14
;;^UTILITY(U,$J,358.3,41235,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41235,1,3,0)
;;=3^DM Type 2 w/ Diab Rtnop w/ Macular Edema
;;^UTILITY(U,$J,358.3,41235,1,4,0)
;;=4^E11.311
;;^UTILITY(U,$J,358.3,41235,2)
;;=E11.319^5002632
;;^UTILITY(U,$J,358.3,41236,0)
;;=E11.319^^152^2030^15
;;^UTILITY(U,$J,358.3,41236,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41236,1,3,0)
;;=3^DM Type 2 w/ Diab Rtnop w/o Macular Edema
;;^UTILITY(U,$J,358.3,41236,1,4,0)
;;=4^E11.319
;;^UTILITY(U,$J,358.3,41236,2)
;;=^5002633
;;^UTILITY(U,$J,358.3,41237,0)
;;=E11.3211^^152^2030^22
;;^UTILITY(U,$J,358.3,41237,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41237,1,3,0)
;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
;;^UTILITY(U,$J,358.3,41237,1,4,0)
;;=4^E11.3211
;;^UTILITY(U,$J,358.3,41237,2)
;;=^5138331
;;^UTILITY(U,$J,358.3,41238,0)
;;=E11.3212^^152^2030^23
;;^UTILITY(U,$J,358.3,41238,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41238,1,3,0)
;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
;;^UTILITY(U,$J,358.3,41238,1,4,0)
;;=4^E11.3212
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2L2 3755 printed Sep 23, 2025@20:06:50 Page 2
IBDEI2L2 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,41226,2)
+2 ;;=^5002659
+3 ;;^UTILITY(U,$J,358.3,41227,0)
+4 ;;=E11.638^^152^2030^29
+5 ;;^UTILITY(U,$J,358.3,41227,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,41227,1,3,0)
+8 ;;=3^DM Type 2 w/ Oth Oral Compl
+9 ;;^UTILITY(U,$J,358.3,41227,1,4,0)
+10 ;;=4^E11.638
+11 ;;^UTILITY(U,$J,358.3,41227,2)
+12 ;;=^5002660
+13 ;;^UTILITY(U,$J,358.3,41228,0)
+14 ;;=E11.641^^152^2030^20
+15 ;;^UTILITY(U,$J,358.3,41228,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,41228,1,3,0)
+18 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
+19 ;;^UTILITY(U,$J,358.3,41228,1,4,0)
+20 ;;=4^E11.641
+21 ;;^UTILITY(U,$J,358.3,41228,2)
+22 ;;=^5002661
+23 ;;^UTILITY(U,$J,358.3,41229,0)
+24 ;;=E11.649^^152^2030^21
+25 ;;^UTILITY(U,$J,358.3,41229,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,41229,1,3,0)
+28 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
+29 ;;^UTILITY(U,$J,358.3,41229,1,4,0)
+30 ;;=4^E11.649
+31 ;;^UTILITY(U,$J,358.3,41229,2)
+32 ;;=^5002662
+33 ;;^UTILITY(U,$J,358.3,41230,0)
+34 ;;=E11.65^^152^2030^17
+35 ;;^UTILITY(U,$J,358.3,41230,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,41230,1,3,0)
+38 ;;=3^DM Type 2 w/ Hyperglycemia
+39 ;;^UTILITY(U,$J,358.3,41230,1,4,0)
+40 ;;=4^E11.65
+41 ;;^UTILITY(U,$J,358.3,41230,2)
+42 ;;=^5002663
+43 ;;^UTILITY(U,$J,358.3,41231,0)
+44 ;;=E11.69^^152^2030^32
+45 ;;^UTILITY(U,$J,358.3,41231,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,41231,1,3,0)
+48 ;;=3^DM Type 2 w/ Oth Spec Compl
+49 ;;^UTILITY(U,$J,358.3,41231,1,4,0)
+50 ;;=4^E11.69
+51 ;;^UTILITY(U,$J,358.3,41231,2)
+52 ;;=^5002664
+53 ;;^UTILITY(U,$J,358.3,41232,0)
+54 ;;=E11.8^^152^2030^34
+55 ;;^UTILITY(U,$J,358.3,41232,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,41232,1,3,0)
+58 ;;=3^DM Type 2 w/ Unspec Compl
+59 ;;^UTILITY(U,$J,358.3,41232,1,4,0)
+60 ;;=4^E11.8
+61 ;;^UTILITY(U,$J,358.3,41232,2)
+62 ;;=^5002665
+63 ;;^UTILITY(U,$J,358.3,41233,0)
+64 ;;=E11.9^^152^2030^35
+65 ;;^UTILITY(U,$J,358.3,41233,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,41233,1,3,0)
+68 ;;=3^DM Type 2 w/o Complications
+69 ;;^UTILITY(U,$J,358.3,41233,1,4,0)
+70 ;;=4^E11.9
+71 ;;^UTILITY(U,$J,358.3,41233,2)
+72 ;;=^5002666
+73 ;;^UTILITY(U,$J,358.3,41234,0)
+74 ;;=E11.29^^152^2030^27
+75 ;;^UTILITY(U,$J,358.3,41234,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,41234,1,3,0)
+78 ;;=3^DM Type 2 w/ Oth Diab Kidney Compl
+79 ;;^UTILITY(U,$J,358.3,41234,1,4,0)
+80 ;;=4^E11.29
+81 ;;^UTILITY(U,$J,358.3,41234,2)
+82 ;;=^5002631
+83 ;;^UTILITY(U,$J,358.3,41235,0)
+84 ;;=E11.311^^152^2030^14
+85 ;;^UTILITY(U,$J,358.3,41235,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,41235,1,3,0)
+88 ;;=3^DM Type 2 w/ Diab Rtnop w/ Macular Edema
+89 ;;^UTILITY(U,$J,358.3,41235,1,4,0)
+90 ;;=4^E11.311
+91 ;;^UTILITY(U,$J,358.3,41235,2)
+92 ;;=E11.319^5002632
+93 ;;^UTILITY(U,$J,358.3,41236,0)
+94 ;;=E11.319^^152^2030^15
+95 ;;^UTILITY(U,$J,358.3,41236,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,41236,1,3,0)
+98 ;;=3^DM Type 2 w/ Diab Rtnop w/o Macular Edema
+99 ;;^UTILITY(U,$J,358.3,41236,1,4,0)
+100 ;;=4^E11.319
+101 ;;^UTILITY(U,$J,358.3,41236,2)
+102 ;;=^5002633
+103 ;;^UTILITY(U,$J,358.3,41237,0)
+104 ;;=E11.3211^^152^2030^22
+105 ;;^UTILITY(U,$J,358.3,41237,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,41237,1,3,0)
+108 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
+109 ;;^UTILITY(U,$J,358.3,41237,1,4,0)
+110 ;;=4^E11.3211
+111 ;;^UTILITY(U,$J,358.3,41237,2)
+112 ;;=^5138331
+113 ;;^UTILITY(U,$J,358.3,41238,0)
+114 ;;=E11.3212^^152^2030^23
+115 ;;^UTILITY(U,$J,358.3,41238,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,41238,1,3,0)
+118 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
+119 ;;^UTILITY(U,$J,358.3,41238,1,4,0)
+120 ;;=4^E11.3212
